Home » Cancer Articles » Aim at Melanoma Secures $4 million in Federal Funding to Study the Effects of UV Radiation on our Service Men and Women Overseas
Aim at Melanoma Secures $4 million in Federal Funding to Study the Effects of UV Radiation on our Service Men and Women Overseas
This came as a result of collaboration between Aim at Melanoma and the U.S. Military, and was key to getting melanoma included for the first time ever in the Department of Defense's peer-reviewed cancer research program.
SAN FRANCISCO, CA, April 03, 2009 /Cancer PR News/ -- It was announced at the CDMRP meeting in Washington, D.C. that Valerie Guild, the President of Aim at Melanoma was responsible for securing $4 million in Federal Funding to study the effects of UV radiation on our service men and women stationed overseas. This came as a result of collaboration between Aim at Melanoma and the U.S. Military, and was key to getting melanoma included for the first time ever in the Department of Defense's peer-reviewed cancer research program.
"We believe that this money will be critical in identifying ways to improve skin cancer prevention and early detection methods for our troops. The funding will also drive research to find potential treatments for all forms of skin cancer, including the most deadly, melanoma. This effort could not have been accomplished without the invaluable help of the U.S. Military," said Valerie Guild, President of Aim at Melanoma.
About Melanoma
In 2008 more than 62,000 people were diagnosed with melanoma, with an estimated 8400 deaths. Although highly treatable in its early stages, there are few treatment options available for later stage patients.
Aim at Melanoma is the largest international melanoma foundation focused on melanoma research, education, awareness, and legislation. The Foundation supports melanoma research efforts by hosting international research forums and is helping to create the first melanoma tissue bank, widely believed by the oncology community to be a key to a major break-through in melanoma research.
Because melanoma is the second most common cancer in 15-29 year olds and the rate of melanoma in young women 15-29 has increased 250% over the last 30 years, Aim at Melanoma continues to pass indoor tanning legislation restricting minors' access to tanning beds.
For more information visit AimAtMelanoma.org the most comprehensive website available to the melanoma community and public at large.
BrandDNA.Inc.
Full-Service LA-based Public Relations & Branding agency. For further information, please contact us at (323) 465-5909.
Source: Aim at Melanoma
Website: http://www.aimatmelanoma.org
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com |
|
|
Press Release Contact Information:
Dan Meyers
BrandDNA, Inc.
CEO
1617 Cosmo Street, Suite 203
Los Angeles, CA
USA 90028
Voice: 323-465-5909
Fax: 323-465-9423
Website: Visit Our Website |
|
|
|
|
|
|
Advertise With Us |
About Us |
Contact Us